肝がん診断市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00003017
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 181
Buy Now

肝臓がん診断市場は、2021 年の 93 億 2,314 万米ドルから 2028 年までに 159 億 5,177 万米ドルに達すると予測されています。この市場は、2021 年から 2028 年にかけて 8.0% の CAGR で成長すると推定されています。



肝臓がんは肝臓の細胞から始まります。肝臓には複数の種類のがんが発生する可能性があります。肝細胞がんは、最も一般的な肝臓がんと考えられており、肝細胞から発生します。米国臨床腫瘍学会 (ASCO) によると、成人の原発性肝がんの約 80% が肝細胞がんです。他のタイプの肝がんには、肝芽腫および肝内胆管がんが含まれます。これらはあまり一般的ではないと考えられています。肝がん診断は、肝がんの識別と確認に使用される技術で構成されています。



戦略的洞察



肝がん診断市場の成長は、肝臓がんの有病率の上昇と、新しい診断検査の開発への研究開発投資の増加。一方、技術的に高度な肝臓がん診断ソリューションの高コストは、市場の成長を妨げています。



肝臓がん診断市場の収益性の高い地域


< TIP>

新しい診断検査の開発における R&D 投資が増加する市場の洞察



肝がんの進行を正確に診断する能力は、適切な治療オプションを選択するために重要です。さらに、さまざまな企業や組織が、需要の高まりに対応して、この病気を早期に特定するための革新的なソリューションを開発および実装するために、多大なイニシアチブを取っています。たとえば、2020 年 3 月、Roche Holding AG の Elecsys GALAD スコアは、米国食品医薬品局 (FDA) から、進行した肝臓がんの早期発見のためのブレークスルー デバイス ステータスを取得しました。スイスの製薬会社の計算機は、年齢、性別、バイオマーカーの結果などの要素を組み合わせて、肝臓がんの最も一般的な形態である早期肝細胞がんを検出します。さらに、Elecsys GALAD スコアは、肝細胞癌のタイムリーで正確な診断を提供することにより、臨床医をサポートするように設計されています。 2021 年の研究開発 (R&D) 支出は 146.5 億ドルで、2020 年には 131.7 億ドルでした。 F.ホフマン・ラ・ロシュ社の研究開発費はコアベースで14%増加しましたが、これは主に腫瘍学、眼科、個別化医療への後期段階の投資によるものです。 2021 年の診断部門の研究開発投資は 18 億 7,892 万米ドルでした。同様に、2019 年 11 月、EXACT Sciences Corporation は、肝臓がんの早期発見のための血液ベースの検査で、食品医薬品局 (FDA) の画期的な指定を受けました。さらに、2020 年 6 月、国立衛生研究所 (NIH) の科学者は、国立がん研究所 (NCI) の研究者が率いる肝臓がんスクリーニングの改善に役立つ血液検査を開発しました。さらに、2019 年 6 月には、リキッドバイオプシー検査である CancerSEEK がジョンズ・ホプキンス大学の研究者によって設計されました。この検査は、胃、肝臓、卵巣、食道などの複数のがんを早期に診断し、早期治療を促進するように設計されています。そのため、研究開発への投資の増加と、肝臓がんを検出するための診断テストの開発が、肝臓がん診断市場を牽引しています。



タイプベースの洞察



世界の肝臓がん診断市場は、タイプに基づいて、臨床検査、内視鏡検査、画像診断、生検などに分割されています。臨床検査セグメントの市場は、血液検査とバイオマーカーにさらに分割されます。臨床検査セグメントは、2021 年に市場で最大のシェアを占めました。ただし、イメージング セグメントは、予測期間中に市場で 8.5% の CAGR を登録すると予想されます。



タイプ別の肝がん診断市場 - 2021 年および 2028 年



エンド ユーザーに基づく洞察



エンドユーザーに基づいて、世界の肝臓がん診断市場は、病院と診断研究所、学術機関と研究機関、および CRO 研究所に分割されます。病院および診断研究所セグメントは、病院が特殊な科学機器を通じて医療施設を提供するため、2021 年に市場で最大のシェアを占めました。訓練を受けたスタッフのチームが、病院の現代医学に関連する問題に対処し、調査し、修復するために割り当てられています。さまざまな医学研究チームが、診断法やその他の医療分野での活動に関連する革新的な技術の導入に常に取り組んでいます。患者は一般的に、高度な治療オプションが利用できるため、病院での肝がん治療を受けることを好みます。病院は患者さんの治療の拠点です。さらに、同じセグメントは、予測期間中に市場で 8.5% の CAGR を登録すると予想されます。



製品の発売と承認は、企業がグローバルなフットプリントを拡大するために一般的に採用する戦略です。肝臓がん診断市場シェアを支配する製品ポートフォリオ。さらに、市場のプレーヤーは、顧客を拡大するためのパートナーシップ戦略に焦点を当てており、その結果、ブランド名をグローバルに維持することができます.肝がん診断の市場シェアは、市場関係者による革新的な新製品の開発により拡大すると予想されます。



会社概要



    < TIP>
  1. アボット

  2. BioMerieux SA

  3. F. HOFFMANN-LA ROCHE LTD

  4. Illumina, Inc.

  5. Koninklijke Philips NV

  6. QIAGEN

  7. Siemens Healthineers AG

  8. THERMO FISHER SCIENTIFIC INC.

  9. GE ヘルスケア

  10. 展望
  11. Helio, Inc.



Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are liver cancer diagnostics?

The abnormal proliferation of cells in the body is referred to as cancer. Cancer of the liver starts in the cells of the liver. The liver can develop a variety of cancers. Hepatocellular carcinoma is the most prevalent type of liver cancer, and it starts in the hepatocyte. Some liver cancers can be detected through screening in persons who are at high risk but do not have symptoms, but most liver cancers are discovered when they produce symptoms. To detect liver disease, a series of blood tests known as liver function tests and imaging studies are employed.

What are the driving factors for the liver cancer diagnostics market across the globe?

Key factors that are driving the growth of this market are the rising prevalence of liver cancer and rising R&D investments for the development of novel diagnostic testing are expected to boost the market growth for liver cancer diagnostics over the years.

What is the market CAGR value of the liver cancer diagnostics market during the forecast period?

The CAGR value of the liver cancer diagnostics market during the forecasted period of 2021-2028 is 8.0%.

Which type led the liver cancer diagnostics market?

The laboratory tests segment held the largest share of the market in the global liver cancer diagnostics market and held the largest market share of 39.61% in 2021.

Which end user held the largest share in the liver cancer diagnostics market?

The hospitals and diagnostic laboratories segment dominated the global liver cancer diagnostics market and accounted for the largest market share of 48.56% in 2021.

Who are the key players in the Liver Cancer Diagnostics market?

The liver cancer diagnostics market majorly consists of players such as Abbott; bioMerieux SA; F. HOFFMANN-LA ROCHE LTD.; Illumina, Inc.; Koninklijke Philips N.V.; QIAGEN; Siemens Healthineers AG; THERMO FISHER SCIENTIFIC INC.; GE Healthcare; Perspectum; Helio, Inc amongst others.

Which are the top companies that hold the market share in liver cancer diagnostics market?

Koninklijke Philips N.V. and Siemens Healthineers AG are the top two companies that hold huge market shares in the liver cancer diagnostics market.

Which region is expected to witness significant demand for the liver cancer diagnostics market in the coming years?

The North America region secures a substantial share of the global liver cancer diagnostics market. The growth of the market in the region is attributed by the rising prevalence of liver cancer. In North America, the US is the largest market for liver cancer diagnostics. The growth of this market is primarily driven by the growing prevalence of liver cancer diseases, technological advancements and developments in the US are going to accelerate the growth of this market in this country.

What is the COVID 19 impact on the Liver Cancer Diagnostics market in the coming years?

The coronavirus disease 2019 (COVID-19) pandemic has caused unprecedented problems to healthcare systems, and patients with liver cancer (LC) may have been particularly affected. COVID-19 may aggravate pre-existing chronic liver damage in HCC patients, complicating cancer treatment. Cancer patients, especially those who have just completed treatment, are at a higher risk of infection and have a poorer prognosis. The first wave of the COVID-19 epidemic had a huge influence on liver cancer patients' normal care. Patients' outcomes may have been considerably harmed as a result of changes to screening, diagnostic, and treatment algorithms. The benefits and drawbacks of the tactics used will be reported through ongoing data collecting and future analysis, assisting future decision-making. However, in the long run, as the vaccination schedule is established and the transmission rate decreases, healthcare systems will return to normal and is expected to experience increased demand for liver cancer diagnostics.

The List of Companies - Liver Cancer Diagnostic Market

  1. Abbott
  2. BioMerieux SA
  3. F. HOFFMANN-LA ROCHE LTD
  4. Illumina, Inc.
  5. Koninklijke Philips N.V
  6. QIAGEN
  7. Siemens Healthineers AG
  8. THERMO FISHER SCIENTIFIC INC.
  9. GE Healthcare
  10. Perspectum
  11. Helio, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports